UK pharmaceutical companies taking clinical trials to Australia
UK-headquartered pharmaceutical companies undertaking clinical trials in order to develop new products "are setting up Australian bases to find out whether their innovations will succeed," according to Nicola Watkinson, senior investment commissioner for Europe at Invest Australia, the Australian government's investment attraction agency.
Australia is rapidly gaining international recognition in the pharmaceutical and biotechnology industries as an attractive environment for conducting clinical trials, the agency points out.
Its reputation has been reinforced by a pharmaceutical benchmarking survey, conducted by the UK's Economist Intelligence Unit, which ranked Australia as the leading location for clinical studies, and ahead of the UK, USA, Germany, India, Japan and Singapore.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze